Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
3(30%)
Results Posted
100%(2 trials)
Terminated
2(20%)

Phase Distribution

Ph phase_2
1
10%
Ph phase_3
1
10%
Ph not_applicable
5
50%
Ph early_phase_1
1
10%
Ph phase_4
1
10%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(5)
Completed(2)
Terminated(3)

Detailed Status

Recruiting3
Not yet recruiting2
Terminated2
Completed2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 21 (11.1%)
Phase 31 (11.1%)
Phase 41 (11.1%)
N/A5 (55.6%)

Trials by Status

not_yet_recruiting220%
withdrawn110%
terminated220%
recruiting330%
completed220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
PROCEDURE
Total Trials
10